Highly Potent Active Pharmaceuticals Ingredients

October 21-22, 2019 | USA

SMi is delighted to announce its Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21st - 22nd October 2019. The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure worker safety.

Spotlight

The US-based company Alcami Corporation is a successful CDMO for the pharmaceutical and biotech industries. Alcami has confirmed its market position through constant adaptations and innovations.


OTHER PAST CONFERENCES

2023 QC Micro Summit

March 21-23, 2023 | USA

Get ready for three days of presentations covering the most important topics affecting pharmaceutical quality control and microbiology, with opportunities to ask questions and network with industry leaders and like-minded peers.

Global Ethnomedicine and Ethnopharmacology Conference (GEEC)

January 17-18, 2023 | UK

Global Ethnomedicine and Ethnopharmacology Conference aims to discuss ongoing developments and new ideas with scholars, researchers, and notable global figures. This will elevate your career, help you build a new network, and present your individual thoughts relating to Medicine

16TH​ ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM

March 1-2, 2023 | Switzerland

For the first time since the pandemic started, we are pleased to announce that the 16th Annual European Life Sciences CEO Forum (ELSF) will take place In-Person on the 1st - 2nd March 2023 back at the Hilton Zurich Airport Hotel.

Pharma Contract Manufacturing

March 28-30, 2023 | Germany

In this time of fast-moving shifts within the industry, increasing supply chain pressures and enhanced global demand for services, the pharma industry is continually looking to leverage external partnerships and engagements.